Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+1.18M
-
Total reported value, excl. options
-
$611M
-
Value change
-
+$25.7M
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$23.02
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q3 2020
88 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q3 2020.
Replimune Group, Inc. - COMMON STOCK (REPL) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 78.4M outstanding shares and own 33.92% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (5.34M shares), Redmile Group, LLC (3.33M shares), Bain Capital Life Sciences Investors, LLC (2.12M shares), BVF INC/IL (1.69M shares), BlackRock Inc. (1.51M shares), VICTORY CAPITAL MANAGEMENT INC (1.19M shares), VANGUARD GROUP INC (1.1M shares), Point72 Asset Management, L.P. (987K shares), NORGES BANK (958K shares), and FMR LLC (919K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.